ZTS Congressional Stock Trades & Insider Buying (2026)

ZTS insider buying and selling over the past year

Insiders at Zoetis Inc. only sold stock in the open market over the past year: 1 Form 4 sales totaling $2.54M, against no open-market purchases.

Most of the selling was pre-scheduled: 1 of the 1 sales (100.0%) were flagged as Rule 10b5-1 plan trades, which are set up in advance and say less about an insider's current view than discretionary sales. Activity clustered in 2026-02 (1 trades); the latest filing in this window is dated 2026-02-17. The average open-market sale price was $127.05; the last close of $79.38 is 37.5% below that level, so sellers exited above the current price. The single largest trade was a sale of 20,000 shares worth $2.54M on 2026-02-17. Since the most recent filing the stock has moved -36.8%, from $125.56.

Where ZTS trades relative to its one-year range

Zoetis Inc. closed at $79.38 on 2026-10-16, inside a one-year range of $69.10 to $147.53. That puts the stock near the bottom of its range, at 13.1% of the distance from low to high. Over one year the share price moved -44.6%, and over roughly three months +3.7%. Average daily volume over the last month was about 4,453,081 shares.

Across 137 companies in the same SEC industry group (SIC 28) with a full year of prices in Gemral Edge, the median one-year return was +12.0%. ZTS is behind that median and beat 9% of that peer group on this measure.

Members of Congress who traded ZTS

STOCK Act disclosures show 97 trades in ZTS by 18 members of Congress over five years (55 purchases, 42 sales), most recently on 2026-09-25. The most active traders were Ro Khanna (D-CA), 56 trades; Gilbert Ray Cisneros, Jr. (D-CA), 9 trades; Jefferson Shreve (R-IN), 4 trades; Lisa C. McClain (R-MI), 4 trades; Markwayne Mullin (R-OK), 4 trades.

By party the trades split 76 by Democrats, 21 by Republicans; by chamber, 91 from the House, 6 from the Senate.

ZTS lobbying disclosures

Zoetis Inc. appears in 4 Lobbying Disclosure Act filings between 2018 and 2018, with $560.0K in reported lobbying spend.

Compare ZTS with indexed peers from the same industry group

These peers have full Gemral Edge dossiers and the closest one-year price move to ZTS:

• EBS one-year return -32.1%
• NVO one-year return -30.8%
• ABT one-year return -17.8%
• IDXX one-year return -12.1%
• AZN one-year return -1.3%

Sources and method

Every figure above is computed from public filings stored in Gemral Edge, not estimated. Insider figures count only open-market purchases and sales reported on SEC Form 4; option exercises, grants and gifts are excluded because they do not reflect a decision to buy or sell at market prices.

• SEC EDGAR Form 4 (edge_insider_trades, codes P/S open-market only) — as of 2026-02-17
• edge_prices_eod (end-of-day close) — as of 2026-10-16
• House PTR / Senate eFD disclosures (edge_congress_trades) — as of 2026-09-25
• Senate LDA filings (edge_lobbying_filings)

ZTS data questions

Are ZTS insiders buying or selling stock?

Insiders at Zoetis Inc. only sold stock in the open market over the past year: 1 Form 4 sales totaling $2.54M, against no open-market purchases.

What is the one-year price range for ZTS?

Based on end-of-day closes through 2026-10-16, ZTS traded between $69.10 and $147.53, last closing at $79.38.

Has any member of Congress traded ZTS stock?

Yes. 18 members disclosed 97 trades in ZTS over five years; the most recent disclosed trade date is 2026-09-25.